In this study, we showed that parthenolide, like the TLR4 antagonist TAK-242, lowers protein levels of TLR4, STAT3 and phosphorylated STAT3 in, and inhibits the proliferation of, melanoma cells. Here, TLR4 is linked to melanoma.